BioDlink International Company Limited (HKG:1875)
5.71
+0.46 (8.76%)
At close: Mar 27, 2026
HKG:1875 Market Cap
HKG:1875 has a market cap or net worth of 4.41 billion as of March 27, 2026. Its market cap has increased by 233.92% in one year.
Market Cap
4.41B
Enterprise Value
4.47B
Revenue
831.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.71
Market Cap Chart
Since November 8, 2019, HKG:1875's market cap has increased from 3.57B to 4.41B, an increase of 23.67%. That is a compound annual growth rate of 3.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 4.06B | 110.00% |
| Dec 24, 2025 | 1.93B | 39.66% |
| Dec 31, 2024 | 1.38B | -9.14% |
| Dec 29, 2023 | 1.52B | -17.92% |
| Dec 30, 2022 | 1.85B | -29.40% |
| Dec 31, 2021 | 2.63B | -0.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jacobio Pharmaceuticals Group | 5.15B |
| Beijing Luzhu Biotechnology | 4.58B |
| Qyuns Therapeutics | 4.25B |
| Shandong Boan Biotechnology | 4.18B |
| Viva Biotech Holdings | 4.12B |
| TYK Medicines | 3.77B |
| Mirxes Holding Company | 3.71B |
| Clover Biopharmaceuticals | 3.57B |